Carbetocin

Acadia gives once-rejected Prader-Willi drug a second chance
BioPharma Dive
Wed, 06/14/23 - 06:40 pm
Acadia Pharmaceuticals
Prader-Willi Syndrome
clinical trials
ACP-101
Carbetocin
Under fire, Cypress pledges $33M to acquire CNS programs
Fierce Biotech
Thu, 08/26/10 - 06:26 pm
Cypress Bioscience
autism
Marina
Carbetocin
Alexa
smoking cessation
Staccato